Skip to content
777 Sourcing.

Capability

tissue-specific mRNA expression targeting

Suppliers
1
States & provinces
1
Countries
1

1 tissue-specific mrna expression targeting supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

COMBINED THERAPEUTICS, INC.

BOSTON, MA

Combined Therapeutics (CTx) is a privately held biotechnology company developing next-generation high-value mRNA vaccines to protect against global infectious diseases and to treat cancer. Its proprietary MOP CTx platform combines Multi Organ Protective binding miRNA sequences with therapeutic mRNAs in lipid nanoparticles to target protein expression to specific tissues while reducing off-target effects and protecting vital organs such as the heart, liver, and kidneys.

mRNA platform developmentvaccine and vaccine adjuvant development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list tissue-specific mRNA expression targeting.

Browse all capabilities